RSV – We move forward with a new clinical trial
We are about to start a new clinical trial for the respiratory syncytial virus RSV. If you are over 60 years old and are interested in participating, do not hesitate to contact us. We are about to start a new clinical trial to evaluate the efficacy and safety of a new medication for the treatment […]
International Clinical Trial Day
May 20 is International Clinical Trial Day, the engine of medical development that saves lives. The emergence of new diseases and health challenges makes clinical studies the key to improving global health. Read the full note in Infobae and learn how these scientific practices are carried out and why they help the growth of the […]
ASTHMA – We move forward with a new clinical trial
A clinical trial is now underway to evaluate the efficacy and safety of a new medication for the treatment of uncontrolled moderate to severe asthma in adult patients. The study will last 12 weeks. For more information about Grupo Sur’s ongoing clinical trials, please visit:https://orchid-swallow-367171.hostingersite.com/en/ensayos-clinicos-ingles/ For more information about ASTHMA: ASTHMA – https://bit.ly/GS-ASMA Asthma Crisis […]
Training course in Clinical Research
Opportunity to expand your knowledge and skills in the field of Clinical Research, under the direction of recognized professionals in the area. Course Start: May 10, 2024Director: María Fernanda AlzogarayCoordinator: María Victoria VulcanoAcademic Secretary: Agustín RomandettaSchedule: Second Friday and Saturday of each monthFace-to-face modality This course represents an exceptional opportunity to expand your knowledge and […]
All you need to know about Dengue
With the increasing incidence of Dengue cases, it is crucial to be well informed. Read our article to learn the details on how to protect yourself and contribute to stopping the spread of the virus. Dengue, a viral disease transmitted by the Aedes Aegypti mosquito, has emerged as a significant threat to public health. With […]
The ANMAT approved the use of the first COVID-19 vaccine developed entirely in Argentina.
This is the ARVAC-Cecilia Grierson vaccine and it will be used as a booster against the COVID-19 variants circulating in the region. ✅ This vaccine, developed by the University of San Martín, scientific personnel from CONICET, and the Cassará laboratory, has proven to be safe and effective as a booster against COVID-19 in individuals over […]
Cesar Milstein Prize
Drs. Analía Mykietiuk and María Fernanda Alzogaray, along with the entire Clinical Research team at the Platense Medical Institute, were recognized for their work with the César Milstein Award in the category of “Health Personnel or Health Institution Committed to Innovation.” The awarding of this mention is linked to the performance of Grupo Sur in […]
